vimarsana.com
Home
Live Updates
Durable immunogenicity of ELI-002 2P in AMPLIFY-201: Lymph n
Durable immunogenicity of ELI-002 2P in AMPLIFY-201: Lymph n
Durable immunogenicity of ELI-002 2P in AMPLIFY-201: Lymph node targeted mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer -April 08, 2024 at 04:52 pm EDT
Public neoantigen:
repertoire4-5
Driver:
Truncal:
...
Related Keywords
San Diego ,
California ,
United States ,
Boston ,
Massachusetts ,
Christopherm Haqq ,
Peterc Demuth ,
Amym Tavares ,
Jamesr Perry ,
Lisak Mcneil ,
Esther Welkowsky ,
Haley Vanwyk ,
Cancer Research ,
Elicio Therapeutics Inc ,
Thian Kheoh ,
Cell Responses Correlate ,
Vaccination Amplifies Cytotoxic ,
Solid Human Cancers ,
Promising Tumor Antigen ,
Reduced Risk ,
Mediant Cell Response ,
Randomized Phase ,
Markets ,